Featured Research

from universities, journals, and other organizations

Schizophrenia gene mutation found; Target for new drugs

Date:

February 23, 2011

Source:

University of California - San Diego

Summary:

In a major advance for schizophrenia research, an international team of scientists has identified a gene mutation strongly linked to the brain disorder -- and a signaling pathway that may be treatable with existing compounds.

Share This

In this family pedigree, the VIPR2 mutation was inherited by at least one of two male offspring who developed schizophrenia (dark squares) from an unaffected mother (circle at top).

Credit: Jonathan Sebat, Ph.D., UC San Diego

In a major advance for schizophrenia research, an international team of scientists, led by Jonathan Sebat, PhD, assistant professor of psychiatry and cellular and molecular medicine at the University of California, San Diego School of Medicine, has identified a gene mutation strongly linked to the brain disorder -- and a signaling pathway that may be treatable with existing compounds.

Related Articles

The work poses significant and immediate implications for neurobiology and the treatment of schizophrenia because the gene identified by the researchers is an especially attractive target for drug development.

"In some ways, this is the kind of gene that the pharmaceutical industry has been waiting for," said Sebat, who is also chief of the Beyster Center for Molecular Genomics of Neuropsychiatric Diseases and a member of the Institute for Genomic Medicine, both at UC San Diego. "Its activity can be modulated by synthetic peptides; and some have already been created."

The findings are published in the Feb. 23, 2011 online issue of the journal Nature.

Schizophrenia is a chronic, severe and disabling brain disorder, with symptoms that include hallucinations, delusions and thought disorders. It is believed to be caused by environmental and genetic factors, most notably the latter: the illness occurs in 1 percent of the general population, or 10 percent of people who have a first-degree relative with the disorder, such as a parent or sibling.

In previous work, Sebat and collaborator Mary-Claire King, a professor of medical genetics at the University of Washington, discovered that rare mutations at many locations in the human genome resulted in significantly higher risk of schizophrenia. These mutations consisted of copy number variants or CNVs -- a type of genetic variation in which the number of copies of a gene differs between individuals. The findings were the first conclusive evidence that rare mutations can cause schizophrenia, but they did not identify the specific genes involved.

The latest study goes much further. Researchers scanned for CNVs in the genomes of 8,290 individuals with diagnosed cases of schizophrenia and 7,431 healthy controls. "We found very strong links to multiple sites in the genome," said Sebat. "Some had been picked up before in earlier studies, but we uncovered a very important new finding: duplications at the tip of chromosome 7q were detected in individuals with schizophrenia at a rate14 times higher than in healthy individuals. These CNVs impact a gene that is important for brain development -- the neuropeptide receptor VIPR2."

Formally known as the Vasoactive Intestinal Peptide Receptor 2, VIPR2 is expressed in the nervous system, including in the brain, blood vessels and gastrointestinal tract. Previous studies have shown that VIPR2 helps to regulate the formation and activity of neurons in the brain. In mice, VIPR2 also has been found to play important roles in behavioral processes, including learning and timing of daily activity.

Sebat and colleagues measured expression of the VIPR2 gene in blood cells from the patients, and they found that individuals with mutations had greater expression of VIPR2 and greater activity of the receptor. "We concluded that the effect of the causal mutations is to raise the volume on the VIP signaling pathway," said Sebat.

"This discovery might be the best target yet to come out of genetic studies of mental illness." said Sebat. "This is what genomic medicine is all about, finding the relevant genes and using this genetic information to come up with a possible strategy for treatment."

Sebat said the next step will be to test whether compounds like these have beneficial effects in mice and in cultured human cells that carry the VIPR2 gene mutation.

Funding for this research came, in part, from the Stanley Medical Research Foundation, the Beyster Family Foundation, the National Alliance for Research on Schizophrenia and Depression and the National Institutes of Health.

University of California - San Diego. "Schizophrenia gene mutation found; Target for new drugs." ScienceDaily. ScienceDaily, 23 February 2011. <www.sciencedaily.com/releases/2011/02/110202132334.htm>.

University of California - San Diego. (2011, February 23). Schizophrenia gene mutation found; Target for new drugs. ScienceDaily. Retrieved March 31, 2015 from www.sciencedaily.com/releases/2011/02/110202132334.htm

University of California - San Diego. "Schizophrenia gene mutation found; Target for new drugs." ScienceDaily. www.sciencedaily.com/releases/2011/02/110202132334.htm (accessed March 31, 2015).

Featured Research

Mar. 31, 2015 — Researchers have illuminated an important distinction between mice and humans: how human livers heal. The difference centers on a protein called PPAR alpha which activates liver ... full story

Mar. 31, 2015 — Researchers have recorded the first direct observations of the micro-scale mechanisms behind the ability of skin to resist tearing. The results could be applied to the improvement of artificial skin, ... full story

Mar. 31, 2015 — Fewer than half of the physicians trained in the United States in 2013 received formal education or training on the subject of exercise, according to new research. "There are immense medical benefits ... full story

Mar. 31, 2015 — Memory and as well as connections between brain cells were restored in mice with a model of Alzheimer's given an experimental cancer drug, researchers report. "With this treatment, cells under ... full story

Mar. 31, 2015 — Increasing state alcohol taxes could prevent thousands of deaths a year from car crashes, say researchers, who found alcohol-related motor vehicle crashes decreased after taxes on beer, wine and ... full story

Mar. 31, 2015 — Alcoholism takes a toll on every aspect of a person's life, including skin problems. Now, a new research report helps explain why this happens and what might be done to address it. "The clinical ... full story

Mar. 31, 2015 — A new population of 'memory' immune cells has been discovered by scientists, throwing light on what the body does when it sees a microbe for the second time. This insight, and others like it, will ... full story

Mar. 31, 2015 — Coronary heart disease and stroke, two of the leading causes of death in the United States, are diseases associated with heightened platelet reactivity. A new study in humans suggests an underlying ... full story

Mar. 31, 2015 — A new study had researchers seeking answers to why the therapeutic benefit afforded by SSRIs was so limited in children and teenagers. If researchers can uncover the biological mechanisms preventing ... full story

Featured Videos

Solitair Device Aims to Takes Guesswork out of Sun Safety

Reuters - Innovations Video Online (Mar. 31, 2015) — The Solitair device aims to take the confusion out of how much sunlight we should expose our skin to. Small enough to be worn as a tie or hair clip, it monitors the user&apos;s sun exposure by taking into account their skin pigment, location and schedule. Matthew Stock reports.
Video provided by Reuters

Soda, Salt and Sugar: The Next Generation of Taxes

Washington Post (Mar. 30, 2015) — Denisa Livingston, a health advocate for the Diné Community Advocacy Alliance, and the Post&apos;s Abby Phillip discuss efforts around the country to make unhealthy food choices hurt your wallet as much as your waistline.
Video provided by Washington Post

S. Leone in New Anti-Ebola Lockdown

AFP (Mar. 28, 2015) — Sierra Leone imposed a three-day nationwide lockdown Friday for the second time in six months in a bid to prevent a resurgence of the deadly Ebola virus. Duration: 01:17
Video provided by AFP

Related Stories

May 16, 2013 — The relationship between the heritable risk for schizophrenia and low intelligence (IQ) has not been clear. Schizophrenia is commonly associated with cognitive impairments that may cause functional ... full story

Jan. 22, 2013 — Researchers have identified a rare gene mutation in a single family with a high rate of schizophrenia, adding to evidence that abnormal genes play a role in the development of the ... full story

Oct. 9, 2012 — Scientists studying a rare genetic disorder have identified a molecular pathway that may play a role in schizophrenia, according to new research. The findings may one day guide researchers to new ... full story

May 12, 2010 — All the major groups of medications for schizophrenia turn up the volume of a brain signal known to be muted in individuals with this psychiatric disorder -- a signal that also can be influenced by ... full story

ScienceDaily features breaking news and videos about the latest discoveries in health, technology, the environment, and more -- from major news services and leading universities, scientific journals, and research organizations.